Radiopharma Player PharmaLogic Snaps Up Lantheus' CDMO Business, Plant as Curium Acquisition Advances
Fierce Pharma
PharmaLogic has made a significant move by acquiring Lantheus' CDMO (Contract Development and Manufacturing Organization) business and plant, building on its recent Curium acquisition.
This strategic decision strengthens PharmaLogic's position in the radiopharma market, offering enhanced capabilities and expanding its production capabilities.